{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:14:50Z","timestamp":1781716490057,"version":"3.54.5"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s13760-026-03014-y","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T09:05:39Z","timestamp":1772096739000},"page":"611-618","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The effect of botulinum neurotoxin injection on non-motor symptoms of cervical dystonia: A prospective cohort"],"prefix":"10.1007","volume":"126","author":[{"given":"Shimelis Girma","family":"Kassaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaat","family":"Paredis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Taelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esayas Kebede","family":"Gudina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"De Hertogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke","family":"De Pauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Crosiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"issue":"7","key":"3014_CR1","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/mds.25475","volume":"28","author":"A Albanese","year":"2013","unstructured":"Albanese A et al (2013) Phenomenology and classification of dystonia: a consensus update. Mov Disord 28(7):863\u2013873. https:\/\/doi.org\/10.1002\/mds.25475","journal-title":"Mov Disord"},{"issue":"8","key":"3014_CR2","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1002\/mds.29387","volume":"38","author":"A Albanese","year":"2023","unstructured":"Albanese A et al (2023) Isolated cervical dystonia: diagnosis and classification. Mov Disord 38(8):1367\u20131378. https:\/\/doi.org\/10.1002\/mds.29387","journal-title":"Mov Disord"},{"issue":"7","key":"3014_CR3","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/mds.23709","volume":"26","author":"DJ Kuyper","year":"2011","unstructured":"Kuyper DJ et al (2011) Nonmotor manifestations of dystonia: a systematic review. Mov Disord 26(7):1206\u20131217. https:\/\/doi.org\/10.1002\/mds.23709","journal-title":"Mov Disord"},{"issue":"9","key":"3014_CR4","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/toxins13090647","volume":"13","author":"M Costanzo","year":"2021","unstructured":"Costanzo M et al (2021) Effect of botulinum toxin on non-motor symptoms in cervical dystonia. Toxins 13(9):647. https:\/\/doi.org\/10.3390\/toxins13090647","journal-title":"Toxins"},{"issue":"7","key":"3014_CR5","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/mds.25501","volume":"28","author":"M Zurowski","year":"2013","unstructured":"Zurowski M et al (2013) Psychiatric comorbidities in dystonia: emerging concepts. Mov Disord 28(7):914\u2013920. https:\/\/doi.org\/10.1002\/mds.25501","journal-title":"Mov Disord"},{"key":"3014_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.parkreldis.2016.06.004","volume":"30","author":"M Smit","year":"2016","unstructured":"Smit M et al (2016) Psychiatric co-morbidity is highly prevalent in idiopathic cervical dystonia and significantly influences health-related quality of life: Results of a controlled study. Parkinsonism Relat Disord 30:7\u201312. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.06.004","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"3014_CR7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/s0022-3999(97)00229-8","volume":"44","author":"T Wenzel","year":"1998","unstructured":"Wenzel T et al (1998) Psychiatric comorbidity in patients with spasmodic torticollis. J Psychosom Res 44(6):687\u2013690. https:\/\/doi.org\/10.1016\/s0022-3999(97)00229-8","journal-title":"J Psychosom Res"},{"issue":"4","key":"3014_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/mds.22983","volume":"25","author":"G Fabbrini","year":"2010","unstructured":"Fabbrini G et al (2010) Psychiatric disorders in adult-onset focal dystonia: a case\u2010control study. Mov Disord 25(4):459\u2013465. https:\/\/doi.org\/10.1002\/mds.22983","journal-title":"Mov Disord"},{"issue":"6","key":"3014_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/ane.13304","volume":"142","author":"V Han","year":"2020","unstructured":"Han V et al (2020) Prevalence of non-motor symptoms and their association with quality of life in cervical dystonia. Acta Neurol Scand 142(6):613\u2013622. https:\/\/doi.org\/10.1111\/ane.13304","journal-title":"Acta Neurol Scand"},{"issue":"3\u20134","key":"3014_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.baga.2014.10.002","volume":"4","author":"L Klingelhoefer","year":"2014","unstructured":"Klingelhoefer L et al (2014) Nonmotor symptoms and focal cervical dystonia: observations from 102 patients. Basal Ganglia 4(3\u20134):117\u2013120. https:\/\/doi.org\/10.1016\/j.baga.2014.10.002","journal-title":"Basal Ganglia"},{"issue":"2","key":"3014_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1136\/bmjopen-2014-005150","volume":"22","author":"J Slawek","year":"2007","unstructured":"Slawek J et al (2007) Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections. Funct Neurol 22(2):95. https:\/\/doi.org\/10.1136\/bmjopen-2014-005150","journal-title":"Funct Neurol"},{"issue":"5","key":"3014_CR12","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/mdc3.12510","volume":"4","author":"M Smit","year":"2017","unstructured":"Smit M et al (2017) The Frequency and Self-perceived Impact on Daily Life of Motor and Non\u2010motor Symptoms in Cervical Dystonia. Mov Disorders Clin Pract 4(5):750\u2013754. https:\/\/doi.org\/10.1002\/mdc3.12510","journal-title":"Mov Disorders Clin Pract"},{"key":"3014_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00702-020-02274-z","volume":"128","author":"L Klingelhoefer","year":"2021","unstructured":"Klingelhoefer L et al (2021) Emotional well-being and pain could be a greater determinant of quality of life compared to motor severity in cervical dystonia. J Neural Transm 128:305\u2013314. https:\/\/doi.org\/10.1007\/s00702-020-02274-z","journal-title":"J Neural Transm"},{"issue":"6","key":"3014_CR14","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/mds.870130613","volume":"13","author":"CM Gudex","year":"1998","unstructured":"Gudex CM et al (1998) Effect of dystonia and botulinum toxin treatment on health-related quality of life. Mov Disorders: Official J Mov Disorder Soc 13(6):941\u2013946. https:\/\/doi.org\/10.1002\/mds.870130613","journal-title":"Mov Disorders: Official J Mov Disorder Soc"},{"issue":"5","key":"3014_CR15","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/jnnp.72.5.608","volume":"72","author":"Y Ben-Shlomo","year":"2002","unstructured":"Ben-Shlomo Y, Camfield L, Warner T (2002) What are the determinants of quality of life in people with cervical dystonia? J Neurol Neurosurg Psychiatry 72(5):608\u2013614. https:\/\/doi.org\/10.1136\/jnnp.72.5.608","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"3014_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1517\/14656566.8.2.129","volume":"8","author":"JJ Ferreira","year":"2007","unstructured":"Ferreira JJ et al (2007) The management of cervical dystonia. Expert Opin Pharmacother 8(2):129\u2013140. https:\/\/doi.org\/10.1517\/14656566.8.2.129","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"3014_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1055\/s-2001-13123","volume":"21","author":"A Brashear","year":"2001","unstructured":"Brashear A (2001) The botulinum toxins in the treatment of cervical dystonia. Semin Neurol 21(1):85\u201390. https:\/\/doi.org\/10.1055\/s-2001-13123","journal-title":"Semin Neurol"},{"issue":"9","key":"3014_CR18","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1007\/s00415-011-5998-9","volume":"258","author":"P Burbaud","year":"2011","unstructured":"Burbaud P et al (2011) Botulinum toxin treatment in neurological practice: how much does it really cost? A prospective cost-effectiveness study. J Neurol 258(9):1670\u20131675. https:\/\/doi.org\/10.1007\/s00415-011-5998-9","journal-title":"J Neurol"},{"issue":"10","key":"3014_CR19","doi-asserted-by":"publisher","first-page":"e005150","DOI":"10.1136\/bmjopen-2014-005150","volume":"4","author":"M Mordin","year":"2014","unstructured":"Mordin M et al (2014) Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled study. BMJ open 4(10):e005150. https:\/\/doi.org\/10.1136\/bmjopen-2014-005150","journal-title":"BMJ open"},{"issue":"4","key":"3014_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.parkreldis.2014.01.004","volume":"20","author":"SR Eichenseer","year":"2014","unstructured":"Eichenseer SR, Stebbins GT, Comella CL (2014) Beyond a motor disorder: a prospective evaluation of sleep quality in cervical dystonia. Parkinsonism Relat Disord 20(4):405\u2013408. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.01.004","journal-title":"Parkinsonism Relat Disord"},{"key":"3014_CR21","doi-asserted-by":"publisher","first-page":"105792","DOI":"10.1016\/j.parkreldis.2023.105792","volume":"114","author":"D Sugar","year":"2023","unstructured":"Sugar D et al (2023) The effect of botulinum toxin on anxiety in cervical dystonia: A prospective, observational study. Parkinsonism Relat Disord 114:105792. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105792","journal-title":"Parkinsonism Relat Disord"},{"key":"3014_CR22","doi-asserted-by":"crossref","unstructured":"Atkin W et al (2017) STROBE statement: Checklist of items that should be included in reports of cohort studies, in The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations. NIHR Journals Library. Available on: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK436220\/","DOI":"10.3310\/hta21250"},{"key":"3014_CR23","doi-asserted-by":"publisher","DOI":"10.1037\/t00742-000","author":"AT Beck","year":"1996","unstructured":"Beck AT, Steer RA, Brown G (1996) Beck depression inventory\u2013II. Psychol Assess. https:\/\/doi.org\/10.1037\/t00742-000","journal-title":"Psychol Assess"},{"key":"3014_CR24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1590\/1516-4446-2012-1048","volume":"35","author":"Y-P Wang","year":"2013","unstructured":"Wang Y-P, Gorenstein C (2013) Psychometric properties of the Beck Depression Inventory-II: a comprehensive review. Brazilian J Psychiatry 35:416\u2013431. https:\/\/doi.org\/10.1590\/1516-4446-2012-1048","journal-title":"Brazilian J Psychiatry"},{"key":"3014_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.clinimag.2019.06.016","volume":"58","author":"Y Sengul","year":"2019","unstructured":"Sengul Y et al (2019) Neuroimaging depression and anxiety in essential tremor: a diffusion tensor imaging study. Clin Imaging 58:96\u2013104. https:\/\/doi.org\/10.1016\/j.clinimag.2019.06.016","journal-title":"Clin Imaging"},{"issue":"3","key":"3014_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/da.10039","volume":"16","author":"E Moraru","year":"2002","unstructured":"Moraru E et al (2002) Relation between depression and anxiety in dystonic patients: implications for clinical management. Depress Anxiety 16(3):100\u2013103. https:\/\/doi.org\/10.1002\/da.10039","journal-title":"Depress Anxiety"},{"key":"3014_CR27","doi-asserted-by":"publisher","unstructured":"Moriarty A et al (2022) Longitudinal follow-up of mood in cervical dystonia and influence on age at onset. Movement disorders clinical practice. 9(5):614\u2013618. https:\/\/doi.org\/10.1002\/mdc3.13457","DOI":"10.1002\/mdc3.13457"},{"key":"3014_CR28","doi-asserted-by":"publisher","first-page":"100049","DOI":"10.1016\/j.prdoa.2020.100049","volume":"3","author":"I Ndukwe","year":"2020","unstructured":"Ndukwe I et al (2020) Mood disorder affects age at onset of adult-onset cervical dystonia. Clin parkinsonism Relat disorders 3:100049. https:\/\/doi.org\/10.1016\/j.prdoa.2020.100049","journal-title":"Clin parkinsonism Relat disorders"},{"issue":"6","key":"3014_CR29","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","volume":"56","author":"AT Beck","year":"1988","unstructured":"Beck AT et al (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56(6):893","journal-title":"J Consult Clin Psychol"},{"issue":"4","key":"3014_CR30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.14744\/hnhj.2023.33349","volume":"63","author":"EK Tur","year":"2023","unstructured":"Tur EK, Carus K\u0130, G\u00f6zke E (2023) Assessment of Non-Motor Symptoms in Cervical Dystonia. Haydarpa\u015fa Numune Med J 63(4):495. https:\/\/doi.org\/10.14744\/hnhj.2023.33349","journal-title":"Haydarpa\u015fa Numune Med J"},{"issue":"2","key":"3014_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ et al (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193\u2013213. https:\/\/doi.org\/10.1016\/0165-1781(89)90047-4","journal-title":"Psychiatry Res"},{"issue":"4","key":"3014_CR32","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1037\/pas0000128","volume":"27","author":"R De la Vega","year":"2015","unstructured":"De la Vega R et al (2015) The Pittsburgh Sleep Quality Index: Validity and factor structure in young people. Psychol Assess 27(4):e22. https:\/\/doi.org\/10.1037\/pas0000128","journal-title":"Psychol Assess"},{"key":"3014_CR33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.smrv.2015.01.009","volume":"25","author":"T Mollayeva","year":"2016","unstructured":"Mollayeva T et al (2016) The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis. Sleep Med Rev 25:52\u201373. https:\/\/doi.org\/10.1016\/j.smrv.2015.01.009","journal-title":"Sleep Med Rev"},{"issue":"1","key":"3014_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/s0022-3999(97)00298-5","volume":"45","author":"JS Carpenter","year":"1998","unstructured":"Carpenter JS, Andrykowski MA (1998) Psychometric evaluation of the Pittsburgh sleep quality index. J Psychosom Res 45(1):5\u201313. https:\/\/doi.org\/10.1016\/s0022-3999(97)00298-5","journal-title":"J Psychosom Res"},{"key":"3014_CR35","doi-asserted-by":"publisher","unstructured":"Balestroni G, Bertolotti G (2012) EuroQol-5D (EQ-5D): an instrument for measuring quality of life. Monaldi Arch Chest Dis 78(3). https:\/\/doi.org\/10.4081\/monaldi.2012.121","DOI":"10.4081\/monaldi.2012.121"},{"key":"3014_CR36","doi-asserted-by":"publisher","unstructured":"Devlin N, Finch AP, Parkin D (2022) Guidance to users of EQ-5D-5L value sets. Value sets for EQ-5D-5L: a compendium, comparative review & user guide, pp. 213\u2013233. https:\/\/doi.org\/10.1007\/978-3-030-89289-0_5","DOI":"10.1007\/978-3-030-89289-0_5"},{"issue":"4","key":"3014_CR37","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/mds.870120414","volume":"12","author":"CL Comella","year":"1997","unstructured":"Comella CL et al (1997) Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale. Mov disorders: official J Mov Disorder Soc 12(4):570\u2013575. https:\/\/doi.org\/10.1002\/mds.870120414","journal-title":"Mov disorders: official J Mov Disorder Soc"},{"issue":"1","key":"3014_CR38","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.parkreldis.2012.02.007","volume":"40","author":"E Consky","year":"1990","unstructured":"Consky E et al (1990) The Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS): assessment of validity and inter-rater reliability. Neurology 40(1):445. https:\/\/doi.org\/10.1016\/j.parkreldis.2012.02.007","journal-title":"Neurology"},{"issue":"12","key":"3014_CR39","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/mdc3.14222","volume":"11","author":"SG Kassaye","year":"2024","unstructured":"Kassaye SG et al (2024) Interdisciplinary Consensus in Evaluating the Severity Subscale of the Original and Revised Toronto Western Spasmodic Torticollis Rating Scale Through Video-Based Assessment: An Inter\u2010Rater Reliability Study. Mov Disorders Clin Pract 11(12):1587\u20131591. https:\/\/doi.org\/10.1002\/mdc3.14222","journal-title":"Mov Disorders Clin Pract"},{"key":"3014_CR40","unstructured":"Consky ES (1994) Clinical assessment of patients with cervical dystonia. Therapy with botulinum toxin, pp. 211\u2013237"},{"key":"3014_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003633.pub4","author":"RE Marques","year":"2020","unstructured":"Marques RE et al (2020) Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Reviews 11 https:\/\/doi.org\/10.1002\/14651858.CD003633.pub4","journal-title":"Cochrane Database Syst Reviews"},{"key":"3014_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2377-14-91","volume":"14","author":"WA Marsh","year":"2014","unstructured":"Marsh WA et al (2014) Systematic review and meta-analysis of the duration of clinical effect of onabotulinumtoxinA in cervical dystonia. BMC Neurol 14:1\u20139. https:\/\/doi.org\/10.1186\/1471-2377-14-91","journal-title":"BMC Neurol"},{"key":"3014_CR43","unstructured":"Qualtrics Qualtrics survey platform. [cited 25 March 2025]; Available from: https:\/\/www.qualtrics.com\/"},{"issue":"8","key":"3014_CR44","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/toxins17080396","volume":"17","author":"M Dudzic","year":"2025","unstructured":"Dudzic M et al (2025) Is There a Non-Motor Effect of Botulinum Toxin Treatment in Cervical Dystonia in Addition to Its Effects on Motor Symptoms? Toxins 17(8):396. https:\/\/doi.org\/10.3390\/toxins17080396","journal-title":"Toxins"},{"issue":"10","key":"3014_CR45","doi-asserted-by":"publisher","first-page":"105160","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105160","volume":"29","author":"H Deveci","year":"2020","unstructured":"Deveci H (2020) Evaluation of the effectiveness of treatment with botulinum toxin on sleep quality in stroke-related spasticity. J Stroke Cerebrovasc Dis 29(10):105160. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.105160","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"4","key":"3014_CR46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.17712\/nsj.2016.4.20160207","volume":"21","author":"VB Safer","year":"2016","unstructured":"Safer VB et al (2016) Effects of botulinum toxin serotype A on sleep problems in children with cerebral palsy and on mothers\u2019 sleep quality and depression. Neurosciences J 21(4):331\u2013337. https:\/\/doi.org\/10.17712\/nsj.2016.4.20160207","journal-title":"Neurosciences J"},{"issue":"1","key":"3014_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3344\/kjp.2011.24.1.1","volume":"24","author":"WS Sim","year":"2011","unstructured":"Sim WS (2011) Application of botulinum toxin in pain management. Korean J pain 24(1):1\u20136. https:\/\/doi.org\/10.3344\/kjp.2011.24.1.1","journal-title":"Korean J pain"},{"issue":"2","key":"3014_CR48","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1213\/01.ane.0000194447.46763.73","volume":"102","author":"T Sycha","year":"2006","unstructured":"Sycha T et al (2006) A lack of antinociceptive or antiinflammatory effect of botulinum toxin A in an inflammatory human pain model. Anesth Analgesia 102(2):509\u2013516. https:\/\/doi.org\/10.1213\/01.ane.0000194447.46763.73","journal-title":"Anesth Analgesia"},{"issue":"1","key":"3014_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40734-016-0047-6","volume":"3","author":"P Termsarasab","year":"2016","unstructured":"Termsarasab P, Thammongkolchai T, Frucht SJ (2016) Medical treatment of dystonia. J Clin Mov disorders 3(1):19. https:\/\/doi.org\/10.1186\/s40734-016-0047-6","journal-title":"J Clin Mov disorders"},{"issue":"1","key":"3014_CR50","doi-asserted-by":"publisher","first-page":"127","DOI":"10.5603\/PJNNS.a2023.0042","volume":"58","author":"M Dec-\u0106wiek","year":"2024","unstructured":"Dec-\u0106wiek M et al (2024) KinesioTaping: impact on non-motor symptoms in cervical dystonia patients treated with botulinum toxin injection. Neurol Neurochir Pol 58(1):127\u2013133. https:\/\/doi.org\/10.5603\/PJNNS.a2023.0042","journal-title":"Neurol Neurochir Pol"},{"key":"3014_CR51","doi-asserted-by":"publisher","DOI":"10.5603\/pjnns.102672","author":"M Dudzic","year":"2025","unstructured":"Dudzic M et al (2025) Does botulinum toxin type A treatment influence non-motor symptoms in cervical dystonia patients? A systematic review. Neurol Neurochir Pol. https:\/\/doi.org\/10.5603\/pjnns.102672","journal-title":"Neurol Neurochir Pol"},{"key":"3014_CR52","doi-asserted-by":"publisher","unstructured":"Dong H et al (2018) Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm. Neuropsychiatr Dis Treat 33\u201336. https:\/\/doi.org\/10.2147\/NDT.S181820","DOI":"10.2147\/NDT.S181820"},{"issue":"5","key":"3014_CR53","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/da.20177","volume":"23","author":"CK Schotte","year":"2006","unstructured":"Schotte CK et al (2006) A biopsychosocial model as a guide for psychoeducation and treatment of depression. Depress Anxiety 23(5):312\u2013324. https:\/\/doi.org\/10.1002\/da.20177","journal-title":"Depress Anxiety"},{"key":"3014_CR54","doi-asserted-by":"publisher","unstructured":"Kongsaengdao S, Maneeton B, Maneeton N (2017) Quality of life in cervical dystonia after treatment with botulinum toxin A: a 24-week prospective study. Neuropsychiatr Dis Treat, pp. 127\u2013132. https:\/\/doi.org\/10.2147\/NDT.S116325","DOI":"10.2147\/NDT.S116325"},{"issue":"10","key":"3014_CR55","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3390\/toxins14100656","volume":"14","author":"K Yoshida","year":"2022","unstructured":"Yoshida K (2022) Effects of botulinum toxin therapy on health-related quality of life evaluated by the oromandibular dystonia rating scale. Toxins 14(10):656. https:\/\/doi.org\/10.3390\/toxins14100656","journal-title":"Toxins"},{"issue":"4","key":"3014_CR56","doi-asserted-by":"publisher","first-page":"e001853","DOI":"10.1136\/bmjopen-2012-001853","volume":"3","author":"H Hefter","year":"2013","unstructured":"Hefter H et al (2013) An open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport). BMJ open 3(4):e001853. https:\/\/doi.org\/10.1136\/bmjopen-2012-001853","journal-title":"BMJ open"},{"key":"3014_CR57","doi-asserted-by":"publisher","first-page":"407","DOI":"10.7916\/D8736R2H","volume":"6","author":"P Jagota","year":"2016","unstructured":"Jagota P et al (2016) Impact of neu-botulinumtoxinA on the severity and quality of life of cervical dystonia patients. Tremor Other Hyperkinetic Movements 6:407. https:\/\/doi.org\/10.7916\/D8736R2H","journal-title":"Tremor Other Hyperkinetic Movements"},{"key":"3014_CR58","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1007\/s00415-016-8185-1","volume":"263","author":"L Nastasi","year":"2016","unstructured":"Nastasi L et al (2016) Effect of botulinum toxin treatment on quality of life in patients with isolated lingual dystonia and oromandibular dystonia affecting the tongue. J Neurol 263:1702\u20131708. https:\/\/doi.org\/10.1007\/s00415-016-8185-1","journal-title":"J Neurol"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03014-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-026-03014-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03014-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T14:43:35Z","timestamp":1780757015000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-026-03014-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["3014"],"URL":"https:\/\/doi.org\/10.1007\/s13760-026-03014-y","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethical Committee of the Antwerp University Hospital (BUN3002023000052). Written informed consent was obtained from all participants. We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}